Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals
- PMID: 30684512
- PMCID: PMC6399029
- DOI: 10.1016/j.jconrel.2019.01.030
Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals
Abstract
Chemophototherapy (CPT) merges photodynamic therapy with chemotherapy and can substantially enhance drug delivery. Using a singular liposomal formulation for CPT, we describe a semi-mechanistic pharmacokinetic-pharmacodynamic (PK/PD) model to investigate observed antitumor effects. Long-circulating, sterically-stabilized liposomes loaded with doxorubicin (Dox) stably incorporate small amounts of a porphyrin-phospholipid (PoP) photosensitizer in the bilayer. These were administered intravenously to mice bearing low-passage, patient-derived pancreatic cancer xenografts (PDX). Dox PK was described with a two-compartment model and tumor drug disposition kinetics were modeled with first-order influx and efflux rates. Tumor irradiation with 665 nm laser light (200 J/cm2) 1 h after liposome administration increased tumor vascular permeabilization and drug accumulation, which was accounted for in the PK/PD model with increased tumor influx and efflux rates by approximately 12- and 4- fold, respectively. This modeling approach provided an overall 7-fold increase in Dox area under the curve in the tumor, matching experimental data (7.4-fold). A signal transduction model based on nonlinear direct cell killing accounted for observed tumor growth patterns. This PK/PD model adequately describes the CPT anti-PDX tumor response based on enhanced drug delivery at the short drug-light interval used.
Keywords: Chemophototherapy; Drug delivery; Pharmacodynamics; Pharmacokinetics; Photodynamic therapy; PoP liposomes.
Copyright © 2019 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Short Drug-Light Intervals Improve Liposomal Chemophototherapy in Mice Bearing MIA PaCa-2 Xenografts.Mol Pharm. 2018 Sep 4;15(9):3682-3689. doi: 10.1021/acs.molpharmaceut.8b00052. Epub 2018 Apr 2. Mol Pharm. 2018. PMID: 29608312
-
PK/PD model for liposomal chemophototherapy.J Control Release. 2019 Mar 10;297:102. doi: 10.1016/j.jconrel.2019.02.022. J Control Release. 2019. PMID: 30827365 No abstract available.
-
Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes.Mol Cancer Ther. 2017 Nov;16(11):2452-2461. doi: 10.1158/1535-7163.MCT-17-0276. Epub 2017 Jul 20. Mol Cancer Ther. 2017. PMID: 28729400 Free PMC article.
-
Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release.Biomaterials. 2016 Jan;75:193-202. doi: 10.1016/j.biomaterials.2015.10.027. Epub 2015 Oct 23. Biomaterials. 2016. PMID: 26513413 Free PMC article.
-
Chemophototherapeutic Ablation of Doxorubicin-Resistant Human Ovarian Tumor Cells.Photochem Photobiol. 2023 Mar;99(2):844-849. doi: 10.1111/php.13677. Epub 2022 Aug 2. Photochem Photobiol. 2023. PMID: 35842741 Free PMC article. Review.
Cited by
-
A review of FDA approved drugs and their formulations for the treatment of breast cancer.Front Pharmacol. 2023 Jul 28;14:1184472. doi: 10.3389/fphar.2023.1184472. eCollection 2023. Front Pharmacol. 2023. PMID: 37576816 Free PMC article. Review.
-
Patient-derived xenograft models in cancer therapy: technologies and applications.Signal Transduct Target Ther. 2023 Apr 12;8(1):160. doi: 10.1038/s41392-023-01419-2. Signal Transduct Target Ther. 2023. PMID: 37045827 Free PMC article. Review.
-
2D Nano-Sonosensitizers Facilitate Energy Transfer to Enhance Sonodynamic Therapy.Adv Mater. 2023 May;35(19):e2212069. doi: 10.1002/adma.202212069. Epub 2023 Mar 26. Adv Mater. 2023. PMID: 36840977 Free PMC article.
-
Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy.Nanomicro Lett. 2023 Feb 8;15(1):44. doi: 10.1007/s40820-023-01018-4. Nanomicro Lett. 2023. PMID: 36752939 Free PMC article. Review.
-
Dual-Functionalized Nanoliposomes Achieve a Synergistic Chemo-Phototherapeutic Effect.Int J Mol Sci. 2022 Oct 24;23(21):12817. doi: 10.3390/ijms232112817. Int J Mol Sci. 2022. PMID: 36361615 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources